2,2'-azobis(2-amidinopropane) has been researched along with Multiple Myeloma in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Firth, CA | 1 |
| Yang, YT | 1 |
| Gieseg, SP | 1 |
1 other study available for 2,2'-azobis(2-amidinopropane) and Multiple Myeloma
| Article | Year |
|---|---|
Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals.
Topics: Amidines; Animals; Cell Survival; Cells, Cultured; Humans; Hydrogen Peroxide; Kinetics; Lipid Peroxi | 2007 |